Stock Quote
Akorn, Inc. (AKRX.W) (NASD ADF)
$1.61
17 Nov 2009
+0.62%
$1.60
$1.61
100
$1.61
$1.61
$2.99
$0.73
1.50
382,421
AKRX.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Kapoor, John | Chairman of the Board | 2,083 |
| Rai, Rajat | Interim Chief Executive Officer | -- |
| Dick, Timothy | Chief Financial Officer | -- |
Profile
Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from outside sources. Its customers... Full Description
Company Address
Akorn, Inc.
2500 Millbrook Drive
Buffalo Grove IL 60089
P: +1847.2796100
F: +1847.2796123
2500 Millbrook Drive
Buffalo Grove IL 60089
P: +1847.2796100
F: +1847.2796123
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Alcon, Inc. | $147.45 | +2.19 |
| Allergan, Inc. | $58.60 | -0.02 |
| Novartis AG | CHF55.15 | +1.20 |
| AKRX.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.57 |
| P/S(TTM) | 1.74 | 0.57 |
| ROI(TTM) | -43.74 | 1.86 |
| ROE(TTM) | -48.65 | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -0.17 |
| Total Revenue | $19.37M |
| Net Income | $-5.10M |
| EPS | $-0.06 |
